DRTS
Alpha Tau Medical LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$906.87M
P/E Ratio
—
EPS
$-0.67
Beta
1.12
52W High
$11.62
52W Low
$2.81
50-Day MA
$8.06
200-Day MA
$5.75
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapies company, is engaged in the research, development, and commercialization of alpha-emitting radiation therapy (Alpha DaRT) for the treatment of solid cancer in Israel and the United States. The company is headquartered in Jerusalem, Israel.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-45.03M |
| Operating Margin | 0.00% |
| Return on Equity | -90.50% |
| Return on Assets | -30.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.77 |
| Price-to-Book | 13.08 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -4.77 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $90.33M |
| Float | $46.43M |
| % Insiders | 31.23% |
| % Institutions | 4.52% |
Historical Volatility
HV 10-Day
128.50%
HV 20-Day
119.03%
HV 30-Day
97.95%
HV 60-Day
80.16%
HV Rank
96.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($13.50 target)
3
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026